Company intelligence
Carlisle Strategic Partners
Bring your Vision to Life™
About Carlisle Strategic Partners
Carlisle Strategic Partners helps life science companies grow, fund, and exit. We provide institutional-grade strategic guidance to early and growth-stage healthcare companies, with a focus on bringing disruptive technologies to market. Our approach is operator-led: rather than one-off consulting, we deliver ongoing advisory that strengthens the business day to day while preparing founders and management teams to navigate every stage of growth, capital, and exit. Our mission is simple — to help you Bring Your Vision to Life™. We work alongside founders across three core areas. Our advisory services span strategic planning, capital allocation, and commercial acceleration. Our proprietary scorecards give leadership teams a clear, diagnostic view of exactly where they stand and what to fix first. And our exit planning and M&A work positions companies for a confident, well-timed sale or transition. What ties it together is a blend of commercial creativity, the nerve to make bold moves, and a gift for building teams that win. Carlisle Strategic Partners is led by Brian Carlisle, an operator-turned-advisor with nearly two decades of experience building, scaling, and selling life sciences companies. Clients don't just get an advisor — they get an experienced partner who has navigated the same challenges they're facing, and who is invested in helping them reach the outcome they're working toward.
Verified activity
Signals from Carlisle Strategic Partners
2 published signals
Capital & Finance
Carlisle Strategic Partners achieved organic revenue doubling, total revenue reaching $80M, and EBITDA growing more than 2.5x following a $20M bolt-on acquisition.
Reported by Brian Carlisle, MBA
Capital & Finance
Carlisle Strategic Partners achieved $80M in revenue through a rebuild of the commercial model, turning individual effort into commercial architecture.
Reported by Brian Carlisle, MBA